GA Good Bad header

The Frustrating: IRF and SRF in a GA Patient

Show Description +

How do you detect and address intraretinal fluid and subretinal fluid in a patient undergoing anti-complement therapy for GA? Rishi Singh, MD, shares a case from his clinic with moderator Judy Kim, MD, and panelists Deepak Sambhara, MD, and Sunir Garg, MD, which illustrates the challenges of treating a patient with suspected cystic characteristics. The group also discusses the use of anti-complement therapies in patients with wet AMD, whether off-label use of GA drugs is warranted, and concomitant management of wet AMD and GA.

Posted: 6/19/2025

Up Next

The Good: Functional Vision, Small GA Lesion, Early Treatment

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD


The Bad: Declining Vision in an Age Before Anti-Complement Therapy

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

The Frustrating: Rapid Atrophy Growth Despite Treatment

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

The Frustrating: IRF and SRF in a GA Patient

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

The Frustrating: IRF and SRF in a GA Patient

How do you detect and address intraretinal fluid and subretinal fluid in a patient undergoing anti-complement therapy for GA? Rishi Singh, MD, shares a case from his clinic with moderator Judy Kim, MD, and panelists Deepak Sambhara, MD, and Sunir Garg, MD, which illustrates the challenges of treating a patient with suspected cystic characteristics. The group also discusses the use of anti-complement therapies in patients with wet AMD, whether off-label use of GA drugs is warranted, and concomitant management of wet AMD and GA.

Posted: 6/19/2025


Please log in to leave a comment.